[go: up one dir, main page]

TW200605917A - Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation - Google Patents

Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation

Info

Publication number
TW200605917A
TW200605917A TW094114826A TW94114826A TW200605917A TW 200605917 A TW200605917 A TW 200605917A TW 094114826 A TW094114826 A TW 094114826A TW 94114826 A TW94114826 A TW 94114826A TW 200605917 A TW200605917 A TW 200605917A
Authority
TW
Taiwan
Prior art keywords
spray
linked
dried powder
saccharose
derivative
Prior art date
Application number
TW094114826A
Other languages
English (en)
Inventor
Stefan Bassarab
Karoline Bechtold-Peters
Richard Fuhrherr
Wolfgang Friess
Patrick Garidel
Torsten Schultz-Fademrecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of TW200605917A publication Critical patent/TW200605917A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
TW094114826A 2004-05-10 2005-05-09 Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation TW200605917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004022926A DE102004022926A1 (de) 2004-05-10 2004-05-10 Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
TW200605917A true TW200605917A (en) 2006-02-16

Family

ID=34966513

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094114826A TW200605917A (en) 2004-05-10 2005-05-09 Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation

Country Status (7)

Country Link
EP (1) EP1778188A1 (zh)
JP (1) JP2007536313A (zh)
KR (1) KR20070037441A (zh)
CA (1) CA2564324A1 (zh)
DE (1) DE102004022926A1 (zh)
TW (1) TW200605917A (zh)
WO (1) WO2005112892A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
CN101304970A (zh) * 2005-12-21 2008-11-12 卫材R&D管理有限公司 1，2-二氢吡啶化合物的无定形物
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010060875A1 (de) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Neue pulverförmige kristalline arzneimittel zur inhalation
WO2010112358A2 (de) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US10192396B2 (en) 2013-02-14 2019-01-29 Cfph, Llc Games using financial indicators as random number generators
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
SG11201608891RA (en) 2014-05-07 2016-11-29 Boehringer Ingelheim Int Nebulizer, indicator device and container
CN107106641B (zh) 2014-10-31 2021-12-21 葛兰素史密斯克莱知识产权发展有限公司 粉末制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5012272A (zh) * 1973-06-01 1975-02-07
KR0161531B1 (ko) * 1990-03-08 1998-11-16 하야시바라 겐 락토수크로오스 고함유 분말의 제조방법과 그 분말의 용도
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
PL187160B1 (pl) * 1994-01-31 2004-05-31 Yamanouchi Pharma Co Ltd Sposób wytwarzania rozpuszczalnej wewnątrzustnie formowanej tłocznie wypraski
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
US5922324A (en) * 1995-01-31 1999-07-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Propolis extract with improved water-solubility
US5892026A (en) * 1995-04-12 1999-04-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo High Trehalose content syrup
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
DE19732351A1 (de) * 1997-07-28 1999-02-04 Hoechst Ag Verfahren zur Herstellung der Süßkraft und zur Geschmacksverbesserung einer Mischung hochintensiver Süßstoffe
JP2004521103A (ja) * 2000-12-21 2004-07-15 ネクター セラピューティックス インターロイキン４レセプターの貯蔵安定性粉末組成物

Also Published As

Publication number Publication date
WO2005112892A1 (de) 2005-12-01
JP2007536313A (ja) 2007-12-13
CA2564324A1 (en) 2005-12-01
DE102004022926A1 (de) 2005-12-15
EP1778188A1 (de) 2007-05-02
KR20070037441A (ko) 2007-04-04

Similar Documents

Publication Publication Date Title
TW200605917A (en) Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NO20060947L (no) β d-krystalinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20064596L (no) Delta-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NO20064588L (no) Delta d-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende den
TW200605897A (en) Powder comprising new compositions of oligosaccharides and methods for their preparation
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
WO2005046603A3 (en) Pyridine compounds
WO2007090882A3 (en) Pharmaceutical extended release compositions comprising pramipexole
MXPA03010207A (es) Nuevas 4-anilinoquinolin-3-carboxamidas.
WO2002074247A3 (en) Pharmaceutical formulations for sustained release
IL164798A0 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
NO20060946L (no) β-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
TW200605905A (en) 1,4 o-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
AR033711A1 (es) Composiciones farmaceuticas
PL370292A1 (en) Formulations for oral administration of active compounds
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
WO2001029055A3 (fr) Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
CA2672094C (en) Methods and apparatus for identifying subject matter in view data
NO20063518L (no) Ny krystallinsk form IV av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
HUP0303763A3 (en) Substituted imidazoles as tafia inhibitors, process for their preparation and pharmaceutical compositions containing them
NO20051414L (no) Fremgangsmate for fremstilling av torrpulverinhaleringssammensetninger